Log In
Print
BCIQ
Print
Print this Print this
 

TSX-002

  Manage Alerts
Collapse Summary General Information
Company TesoRx Pharma LLC
DescriptionOral pro-liposomal formulation of unmodified testosterone
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today